CRNX

Crinetics Pharmaceuticals, Inc.

Healthcare · Biotechnology

$262.11 sample

+2.26 (+0.87%) 1D

Market cap

$988.6B

Price as of

2026-10-15

Latest filing

8-K · 2026-08-14

Alerts

8

Price$262.11 +38.75% 3M daily closessample

262.11188.91

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider sell: Director
Sep 29INSInsider buy: Chief Financial Officer
Sep 24INSInsider sell: Chief Financial Officer
Sep 21INSInsider buy: General Counsel
Sep 10INSInsider buy: General Counsel
Sep 02INSInsider sell: Director
Aug 25INSInsider sell: Director
Aug 14SEC10-Q filed

Sign up to see the real CRNX record →

Company facts

SEC EDGAR registration

Name: Crinetics Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +40sample, -100 to +100
Reporting currency: USD

Who is positioning in CRNX

sample

Insiders: 8 insider transactions over 90 days, net selling, $219.8M
Congress: No member trades over 90 days
Institutions · 13F: 44 funds hold $11.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$31.0B +22.0% y/y

Q4 2024Q3 2026

Inventory$17.4B +4.5% y/y

Q4 2024Q3 2026

Accounts receivable$13.4B +14.4% y/y

Q4 2024Q3 2026

Total debt$36.4B +15.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $771.9B +8.8% 3M
Sample peer B: $113.8B +4.7% 3M
Sample peer C: $703.3B +4.8% 3M
Sample peer D: $512.4B -1.4% 3M
Sample peer E: $420.1B -12.6% 3M